NL-OMON38595已完成不适用
Bioavailability of oral ciprofloxacin tablets versus suspension in pediatric cancer patients - BioCip
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 至 99（—）
入选标准
- •- Age *1 years and < 19 years
- •- Patients treated with chemotherapy for pediatric cancer
- •- Patients who will receive ciprofloxacin treatment as antimicrobial prophylaxis according to standard supportive care guidelines
排除标准
- •- Patients unable/unwilling to take one of the ciprofloxacin formulations
- •- Patients with cystic fibrosis
- •- Patients with celiac disease
- •- Patients with abnormalities in the gastrointestinal tract, including severe chemotherapy induced mucositis/diarrhea
- •- Known or suspected malabsorption state
- •- Previous allergic reactions to fluorchinolones
- •- Hepatic insufficiency
研究者
相似试验
进行中（未招募）
1 期
The availability of ciprofloxacin in the body after administration of tablets and suspension in pediactric cancer patientsMicrobial prophylaxis during cancer treatmentEUCTR2013-002744-89-NLErasmus MC
暂停
不适用
Bioavailability of oral ciprofloxacin tablets versus suspension in pediatric cancer patientsCancerAntimicrobial prophylaxisBioequivalenceCiprofloxacinNL-OMON24417Erasmus Medical Center15
已完成
不适用
A study of the concentration of ciprofloxacin in the body over time when given by mouthSevere acute malnutritionNutritional, Metabolic, EndocrineUnspecified protein-energy malnutritionISRCTN31079753Kenya Medical Research Institute (KEMRI) Wellcome Trust Research Programme (Kenya)52
进行中（未招募）
不适用
Investigation of pharmacokinetics of Ciprofloxacin and Piperacillin/Tazobactam in Patients receiving continuous renal replacement therapyEUCTR2010-021369-66-DEDepartment of Pharmacy Universitaetsmedizin Mainz40
已完成
不适用
To study ciprofloxacin pharmacokinetics in patients who are critically ill and undergoing continuous dialysisPatients on dialysisNutritional, Metabolic, EndocrineRenal failureISRCTN52722850Trinity College Dublin (Ireland)7